Coumarin Supercharges Natural Killer Cells to Fight Liver Cancer, Study Finds

A naturally occurring plant compound best known for its sweet, hay-like scent may hold an unexpected weapon against one of the world’s deadliest cancers. In a new preclinical study published in Medical Oncology, researchers in China report that coumarin, a small molecule found in a variety of plants including the traditional medicinal herb Sophora tonkinensis, can dramatically ramp up the cancer-killing activity of natural killer cells and shrink liver tumors in mice. The work, led by Jincai Wen, Yuanyuan Guo, and Xianling Wang under the supervision of Xiaoyan Zhan, Xiaohe Xiao, and Zhaofang Bai, offers a detailed look at how a simple botanical constituent might be repurposed as an immunotherapy booster for hepatocellular carcinoma, the most common form of liver cancer.

Natural killer cells, or NK cells, are the immune system’s rapid-response assassins. Unlike T cells, which must be trained to recognize specific molecular targets, NK cells patrol the body and destroy cells that display telltale signs of stress or malignancy, without prior sensitization. In the liver, however, NK cells often find themselves outmaneuvered. The tumor microenvironment of hepatocellular carcinoma is notoriously immunosuppressive, and exhausted, metabolically starved NK cells frequently lose their ability to produce the toxic arsenal needed to kill cancer cells. Restoring that lost vigor has become a major goal of immunotherapy research, and the new study suggests that a plant-derived compound may help do exactly that.

The investigation began as a screen of Sophora tonkinensis extract, a herb long used in traditional Chinese medicine, against NK-92 cells, a human natural killer cell line widely used in immunology research. Among the active constituents, coumarin stood out for its ability to promote NK cell activation. The team measured cytokine output by enzyme-linked immunosorbent assay, quantified the cytotoxic proteins granzyme B and perforin by western blot and quantitative polymerase chain reaction, and profiled surface receptors by flow cytometry. Crucially, they then repeated the key experiments in primary human NK cells, strengthening the case that the effect is not an artifact of a laboratory-adapted cell line.

The results were striking. Coumarin acted synergistically with interleukin-12, a powerful inflammatory signal that primes NK cells for battle. Together, the two agents pushed NK cells to transcribe, produce, and secrete markedly higher levels of interferon-gamma, the signature cytokine of NK cell activation, along with elevated amounts of granzyme B and perforin, the pore-forming and enzyme-carrying proteins that NK cells use to punch lethal holes in tumor cells. In both NK-92 cells and primary human NK cells, the combination produced a measurable shift toward a more cytotoxic, inflammatory state, suggesting that coumarin could amplify signals that immunotherapies already try to exploit.

To test whether this cellular activation translated into real anti-tumor power, the researchers turned to an H22 hepatocellular carcinoma syngeneic mouse model, in which the animals’ immune systems are intact and able to mount a genuine response against the tumor. Mice treated with coumarin showed significantly reduced tumor volume compared with controls. Flow cytometry of spleen and tumor tissue revealed that the compound increased the infiltration of both NK cells and CD8-positive T cells into the tumor microenvironment, hinting that coumarin does more than simply energize individual cells; it appears to help remodel the immune landscape of the tumor itself, drawing in the very cell types most capable of attacking cancer.

The most technically intriguing part of the study lies in its exploration of metabolism. Transcriptome sequencing of treated NK cells identified 194 upregulated genes and 67 downregulated genes, with the altered genes enriched in energy metabolism pathways. Follow-up Seahorse metabolic analysis, a technique that measures cellular respiration in real time, showed that coumarin significantly increased the oxygen consumption rate of NK cells, a direct indicator of mitochondrial respiratory activity. In other words, the compound appears to restore the energy supply that NK cells need to sustain their demanding killing program, addressing a well-documented vulnerability of NK cells in tumors, where metabolic competition from cancer cells leaves immune cells running on empty.

This metabolic angle connects the findings to a growing body of literature on NK cell bioenergetics. Previous work has shown that mitochondrial fragmentation limits NK cell-based tumor immunosurveillance, and that metabolic fitness is tightly linked to cytotoxic capacity. By boosting oxygen consumption and shifting the transcriptional profile of NK cells toward energy production, coumarin may be recharging the cellular power plants that tumors deliberately drain. The authors are careful, however, to note the limits of the evidence: the current data demonstrate elevated mitochondrial respiratory capacity but do not confirm comprehensive metabolic reprogramming, nor do they identify the direct molecular targets of coumarin within the cell.

That candor matters, because the path from a preclinical observation to a clinical therapy is long and uncertain. Coumarin itself has a complicated pharmacological history; the parent compound is not without toxicity concerns at high doses, and its use as a fragrance agent has been restricted in some contexts. The study also relies on a single syngeneic mouse model, and the effects of IL-12, while potent, have historically been difficult to deploy safely in patients because of systemic inflammatory side effects. Whether coumarin can enhance NK cell function in human tumors at achievable and safe exposures remains an open question that will require pharmacokinetic studies, toxicity testing, and eventually carefully designed clinical trials.

Still, the study adds to a compelling pattern in natural product research. Other plant-derived molecules, including daphnetin, another coumarin-family compound previously identified in screens for NK cell activators, ginsenosides from Panax ginseng, schisandrin C, and various flavonoids, have all shown immunomodulatory effects in recent years. The Chengdu University of Traditional Chinese Medicine and Chinese PLA General Hospital team, whose work was supported by the National Natural Science Foundation of China and other national and Beijing research programs, has previously explored how botanical compounds modulate innate immune pathways such as cGAS-STING. The new findings extend that program into NK cell biology and tumor immunotherapy, suggesting that traditional medicine libraries remain a rich source of immune-active chemistry.

For hepatocellular carcinoma patients, the stakes are high. Liver cancer is a leading cause of cancer death worldwide, and while immune checkpoint inhibitors and tyrosine kinase inhibitors have improved outcomes in recent years, many patients do not respond or eventually relapse. Approaches that boost innate immunity, particularly NK cell function, represent an attractive complementary strategy, and the idea that a well-characterized small molecule could potentiate existing cytokine signals is appealing from both a cost and a combinability standpoint. The authors conclude that coumarin serves as a promising preclinical natural product candidate for liver cancer immunotherapy, one that inhibits tumor growth by improving NK cell cytotoxic function, remodeling the tumor immune microenvironment, and enhancing mitochondrial bioenergetic activity. If follow-up studies can pin down the direct molecular target of coumarin and validate the effect in additional models, this fragrant old molecule may yet earn a new role in the modern immunotherapy arsenal.

Subject of Research: Coumarin-mediated activation of NK cells as a potential immunotherapy mechanism against hepatocellular carcinoma

Article Title: Mechanism of Coumarin in the anti-liver cancer activity by promoting NK cell activation

Article References: Mechanism of Coumarin in the anti-liver cancer activity by promoting NK cell activation. (n.d.). https://doi.org/10.1007/s12032-026-03413-4

Image Credits: AI Generated

DOI: 10.1007/s12032-026-03413-4

Keywords: coumarin, natural killer cells, hepatocellular carcinoma, liver cancer, immunotherapy, interleukin-12, interferon-gamma, granzyme B, perforin, mitochondrial metabolism, Sophora tonkinensis, tumor microenvironment